225 related articles for article (PubMed ID: 30384258)
1. Dihomo-γ-linolenic acid inhibits growth of xenograft tumors in mice bearing human pancreatic cancer cells (BxPC-3) transfected with delta-5-desaturase shRNA.
Yang X; Xu Y; Gao D; Yang L; Qian SY
Redox Biol; 2019 Jan; 20():236-246. PubMed ID: 30384258
[TBL] [Abstract][Full Text] [Related]
2. Dihomo-γ-linolenic acid inhibits xenograft tumor growth in mice bearing shRNA-transfected HCA-7 cells targeting delta-5-desaturase.
Xu Y; Yang X; Gao D; Yang L; Miskimins K; Qian SY
BMC Cancer; 2018 Dec; 18(1):1268. PubMed ID: 30567534
[TBL] [Abstract][Full Text] [Related]
3. Knockdown delta-5-desaturase promotes the formation of a novel free radical byproduct from COX-catalyzed ω-6 peroxidation to induce apoptosis and sensitize pancreatic cancer cells to chemotherapy drugs.
Yang X; Xu Y; Brooks A; Guo B; Miskimins KW; Qian SY
Free Radic Biol Med; 2016 Aug; 97():342-350. PubMed ID: 27368132
[TBL] [Abstract][Full Text] [Related]
4. Knockdown delta-5-desaturase in breast cancer cells that overexpress COX-2 results in inhibition of growth, migration and invasion via a dihomo-γ-linolenic acid peroxidation dependent mechanism.
Xu Y; Yang X; Wang T; Yang L; He YY; Miskimins K; Qian SY
BMC Cancer; 2018 Mar; 18(1):330. PubMed ID: 29587668
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of delta-5-desaturase promotes the anti-cancer activity of dihomo-γ-linolenic acid and enhances the efficacy of chemotherapy in colon cancer cells expressing COX-2.
Xu Y; Yang X; Zhao P; Yang Z; Yan C; Guo B; Qian SY
Free Radic Biol Med; 2016 Jul; 96():67-77. PubMed ID: 27101738
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cancer migration and invasion by knocking down delta-5-desaturase in COX-2 overexpressed cancer cells.
Yang X; Xu Y; Wang T; Shu D; Guo P; Miskimins K; Qian SY
Redox Biol; 2017 Apr; 11():653-662. PubMed ID: 28157665
[TBL] [Abstract][Full Text] [Related]
7. Specific delivery of delta-5-desaturase siRNA via RNA nanoparticles supplemented with dihomo-γ-linolenic acid for colon cancer suppression.
Xu Y; Pang L; Wang H; Xu C; Shah H; Guo P; Shu D; Qian SY
Redox Biol; 2019 Feb; 21():101085. PubMed ID: 30584980
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibitory and anti-metastatic activity of epithelial cell adhesion molecule targeted three-way junctional delta-5-desaturase siRNA nanoparticle for breast cancer therapy.
Shah H; Pang L; Wang H; Shu D; Qian SY; Sathish V
Nanomedicine; 2020 Nov; 30():102298. PubMed ID: 32931930
[TBL] [Abstract][Full Text] [Related]
9. Iminodibenzyl redirected cyclooxygenase-2 catalyzed dihomo-γ-linolenic acid peroxidation pattern in lung cancer.
Pang L; Shah H; Qian S; Sathish V
Free Radic Biol Med; 2021 Aug; 172():167-180. PubMed ID: 34102280
[TBL] [Abstract][Full Text] [Related]
10. Free radical derivatives formed from cyclooxygenase-catalyzed dihomo-γ-linolenic acid peroxidation can attenuate colon cancer cell growth and enhance 5-fluorouracil's cytotoxicity.
Xu Y; Qi J; Yang X; Wu E; Qian SY
Redox Biol; 2014; 2():610-8. PubMed ID: 25114837
[TBL] [Abstract][Full Text] [Related]
11. EpCAM-Targeted 3WJ RNA Nanoparticle Harboring Delta-5-Desaturase siRNA Inhibited Lung Tumor Formation via DGLA Peroxidation.
Pang L; Shah H; Wang H; Shu D; Qian SY; Sathish V
Mol Ther Nucleic Acids; 2020 Dec; 22():222-235. PubMed ID: 33230429
[TBL] [Abstract][Full Text] [Related]
12. Silencing pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer cells to gemcitabine.
Gao CC; Xu XL; Li F; Gong BG; Liu S; Cui YQ; Sun HC; Xu PY; Zheng YM; Jiang H
Tumour Biol; 2016 Jun; 37(6):7555-64. PubMed ID: 26684804
[TBL] [Abstract][Full Text] [Related]
13. [An experimental study of gemcitabine inducing pancreatic cancer cell apoptosis potentiated by nuclear factor-kappa B P65 siRNA].
Kong R; Sun B; Wang SJ; Pan SH; Wang G; Chen H; Xue DB; Jiang HC
Zhonghua Wai Ke Za Zhi; 2010 Jan; 48(2):128-33. PubMed ID: 20302733
[TBL] [Abstract][Full Text] [Related]
14. Delta-5-desaturase: A novel therapeutic target for cancer management.
Pang L; Shah H; Xu Y; Qian S
Transl Oncol; 2021 Nov; 14(11):101207. PubMed ID: 34438249
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of serum dihomo-γ-linolenic acid level and estimated Δ-5 desaturase activity in patients with hepatic steatosis.
Matsuda M; Kawamoto T; Tamura R
Obes Res Clin Pract; 2017; 11(1):34-43. PubMed ID: 26964726
[TBL] [Abstract][Full Text] [Related]
16. Iminodibenzyl induced redirected COX-2 activity inhibits breast cancer progression.
Shah H; Pang L; Qian S; Sathish V
NPJ Breast Cancer; 2021 Sep; 7(1):122. PubMed ID: 34535685
[TBL] [Abstract][Full Text] [Related]
17. VEGF-C ShRNA inhibits pancreatic cancer growth and lymphangiogenesis in an orthotopic fluorescent nude mouse model.
Shi Y; Tong M; Wu Y; Yang Z; Hoffman RM; Zhang Y; Tian Y; Qi M; Lin Y; Liu Y; Dai L; Sun Y; Wang Z
Anticancer Res; 2013 Feb; 33(2):409-17. PubMed ID: 23393331
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting signal transducer and activator of transcription-3 increases response to gemcitabine and delays progression of pancreatic cancer.
Venkatasubbarao K; Peterson L; Zhao S; Hill P; Cao L; Zhou Q; Nawrocki ST; Freeman JW
Mol Cancer; 2013 Sep; 12(1):104. PubMed ID: 24025152
[TBL] [Abstract][Full Text] [Related]
19. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
Gu WJ; Liu HL
Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
[TBL] [Abstract][Full Text] [Related]
20. The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer.
Dineen SP; Sullivan LA; Beck AW; Miller AF; Carbon JG; Mamluk R; Wong H; Brekken RA
BMC Cancer; 2008 Nov; 8():352. PubMed ID: 19038046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
